AmpliPhi Biosciences COO Igor Bilinsky receives $708.5K in 2017
AmpliPhi Biosciences reports 2017 executive compensation
Published: December 31, 1969
AmpliPhi Biosciences reported fiscal year 2017 executive compensation information on December 31, 1969.
In 2017, four executives at AmpliPhi Biosciences received on average a compensation package of $640.1K, a 44% increase compared to previous year.Average pay of disclosed executives at AmpliPhi Biosciences
Igor Bilinsky, Chief Operating Officer, received $708.5K in total. 45.66% of Bilinsky's compensation, or $323.5K, was in salary. Bilinsky also received $183.8K in non-equity incentive plan and $201.2K in option awards.
Michael Scott Salka, Chief Executive Officer, received a compensation package of $704.4K, which increased by 33% compared to previous year. 35.19% of the compensation package, or $247.9K, was in other compensation.
Steve Martin, Chief Financial Officer, earned $647.5K in 2017, a 5% increase compared to previous year.
Paul Grint, Chief Executive Officer, received $500K in 2017, which increases by 1011% compared to 2016.